Molecular Epidemiology of Wild Poliovirus Transmission

  • Olen M. Kew
  • Baldev K. Nottay
  • Rebeca Rico-Hesse
  • Mark A. Pallansch
Part of the Applied Virology Research book series (AVIR, volume 2)

Abstract

Paralytic poliomyelitis is a serious and highly visible public health problem in most developing countries, where up to 400,000 children are stricken each year (Assaad and Ljungars-Esteves, 1984; Sabin, 1985). Large areas of Asia, Africa, North America, and South America are currently endemic for this disease. In many urban centers of the developing world, attack rates are particularly high. The epidemiologic situation in Bombay, where the annual incidence of poliomyelitis cases in that one city alone is over 100-fold higher than in the United States and Canada combined (Enterovirus Research Centre, Bombay, 1987; Pan American Health Organization, 1987; World Health Organization, 1988), underscores the magnitude of the problem that still awaits resolution.

Keywords

Molecular Epidemiology Oral Poliovaccine Paralytic Poliomyelitis Wild Isolate Wild Poliovirus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson, R. P., Young, J. F., and Palese, P. (1982). Nucleic Acids Res. 10, 237–246.PubMedCrossRefGoogle Scholar
  2. Assaad, F., and Ljungars-Esteves, K. (1984). Rev. Infect. Dis. 6 (Suppl 2), S302 - S307.PubMedCrossRefGoogle Scholar
  3. Biggin, M. D., Gibson, T. J., and Hong, G. F. (1983). Proc. Natl. Acad. Sci. USA 80, 3963–3965.PubMedCrossRefGoogle Scholar
  4. Buonagurio, D. A., Nakada, S., Fitch, W. A., and Palese, P. (1986a). Virology 153, 12–21.PubMedCrossRefGoogle Scholar
  5. Buonagurio, D. A., Nakada, S., Parvin, J. D., Krystal, M., Palese, P., and Fitch, W. M. (1986b). Science 232, 980–982.PubMedCrossRefGoogle Scholar
  6. Carp, R. I., Plotkin, S. A., Norton, T. W., and Koprowski, H. (1963). Proc. Soc. Exp. Biol. Med. 112, 25 1256.Google Scholar
  7. Crainic, R., Couillin, P., Blondel, B., Cabau, N., Boue, A., and Horodniceanu, F. (1983). Infect. Immun. 41, 1217–1225.PubMedGoogle Scholar
  8. da Silva, E. E., Schatzmayr, H. G., and Kew, O. M. (1990). Braz. J. Biol. Med. Sci. (in press).Google Scholar
  9. Domingo, E., Davila, M., and Orrin, J. (1980). Gene 11, 333–346.PubMedCrossRefGoogle Scholar
  10. Enterovirus Research Centre, Bombay (1987). Annual Report of Poliomyelitis Surveillance. Indian Council of Medical Research, New Delhi.Google Scholar
  11. Evans, A. S. (1984). Prog. Med. Virol. 29, 141–165.PubMedGoogle Scholar
  12. Fitch, W. M., and Margoliash, E. (1967). Science 155, 279–284.PubMedCrossRefGoogle Scholar
  13. Henderson, R. H. (1984). Rev. Infect. Dis. 6 (Suppl 2), S475 - S479.PubMedCrossRefGoogle Scholar
  14. Hogle, J. M., Chow, M., and Filman, D. J. (1985). Science 229, 1353–1365.CrossRefGoogle Scholar
  15. Hughes, P. J., Evans, D. M. A., Minor, P. D., Schild, G. C., Almond, J. W., and Stanway, G. (1986). J. Gen. Virol. 67, 2093–2102.PubMedCrossRefGoogle Scholar
  16. Humphrey, D. D., Kew, O. M., and Feorino, P. M. (1982). Infect. Immun. 36, 841–843.PubMedGoogle Scholar
  17. Huovilainen, A., Kinnunen, L., Ferguson. M., and Hovi, T. (1988). J. Gen. Virol. 69, 1941–1948.PubMedCrossRefGoogle Scholar
  18. Jablonski, E., Moomaw, E. W., Tullis, R. H., and Ruth, J. L. (1986). Nucleic Acids Res. 14, 6115–6128.PubMedCrossRefGoogle Scholar
  19. Kew, O. M., and Nottay, B. K. (1984a). Rev. Infect. Dis. 6 (Suppl 2), S499 - S504.PubMedCrossRefGoogle Scholar
  20. Kew, O. M., and Nottay, B. K. (1984b). In Modern Approaches to Vaccines (R. Chanock and R. Lerner, eds.), pp. 357–362, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.Google Scholar
  21. Kew, O. M., and Nottay, B. K. (1986). In Concepts in Viral Pathogenesis, Vol. 2 (A. L. Notkins and M. B. A. Oldstonc, eds.), pp. 317–323. Springer-Verlag, New York.Google Scholar
  22. Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H., and Obijeski, J. F. (1981). J. Gen Virol. 56, 337–347.PubMedCrossRefGoogle Scholar
  23. Kew, O. M., Nottay, B. K., and Obijeski, J. F. (1984). In Methods in Virology, Vol. 8 (K. Maramorosch and H. Koprowski, eds.), pp. 41–84, Academic Press, New York.Google Scholar
  24. Kim-Farley, R. J., Bart, K. J., Schonberger, L. B., Orenstein, W. A., Nkowane, B. M., Hinman, A. R., Kew, O. M., Hatch, M. H., and Kaplan, J. E. (1984). Lancet 2, 1315–1317.PubMedCrossRefGoogle Scholar
  25. Kostrzewski, J., Kulesza, A., and Abgarowicz, A. (1970). Epidemiol. Rev. 34, 89–103.Google Scholar
  26. La Monica, N., Meriam, C., and Racaniello, V. R. (1986). J. Virol. 57, 515–525.PubMedGoogle Scholar
  27. Meinkoth, J., and Wahl, G. (1984). Anal. Biochem. 138, 267–284.PubMedCrossRefGoogle Scholar
  28. Metcalf, T. G., Jiang, X., Estes, M. K., and Melnick, J. L. (1988). Prog. Med. Virol. 35, 186–214.PubMedGoogle Scholar
  29. Minor, P. D., Schild, G. C., Ferguson, M., Mackay, A., Magrath, D. I., John, A., Yates, P. J., and Spitz, M. (1982). J. Gen. Virol. 61, 167–176.PubMedCrossRefGoogle Scholar
  30. Minor, P. D., Ferguson, M., Evans, D. M. A., Almond, J. W., and Icenogle, J. P. (1986a). J. Gen Viro!. 67, 1283–1291.CrossRefGoogle Scholar
  31. Minor, P. D., John, A., Ferguson, M., and Icenogle, J. P. (1986b). J. Gen. Virol. 67, 693–706.PubMedCrossRefGoogle Scholar
  32. Nakano, J. H., Gelfand, H. M., and Cole, J. T. (1963). Am. J. Hyg. 78, 214–226.PubMedGoogle Scholar
  33. Nakano, J. H., Hatch, M. H., Thieme, M. L., and Nottay, B. (1978). Prog. Med. Viro!. 24, 178–206.Google Scholar
  34. Nkowane, B. M., Wassilak, S. G. F., Orenstein, W. A., Bart, K. J., Schonberger, L. B., Hinman, A. R., and Kew, O. M. (1987). DAMA 257, 1335–1340.CrossRefGoogle Scholar
  35. Nomoto, A., Ornata, T., Toyoda, H., Kuge, S., Hone, H., Kataoka, Y., Genba, Y., Nakano, Y., and Imura, N. (1982). Proc. Nati. Acad. Sci. USA 79, 5793–5797.CrossRefGoogle Scholar
  36. Nottay, B. K., Kew, O. M., Hatch, M. H., Heyward, J. T., and Obijeski, J. F. (1981). Virology 108, 405–423.PubMedCrossRefGoogle Scholar
  37. Osterhaus, A. D. M. E., van Wezel, A. L., Hazendonk, T. G., UytdeHaag, F. G. C. M., van Asten, J. A. A. M., and van Steenis, B. (1983). Intervirology 20, 129–136.PubMedCrossRefGoogle Scholar
  38. Page, G. S., Mosser, A. G., Hogle, J. M., Filman, D. J., Rueckert, R. R., and Chow, M. (1988). J. Viro!. 62, 1781–1794.Google Scholar
  39. Pan American Health Organization (1985). Eradication of Indigenous Transmission of the Wild Poliovirus from the Americas, Plan of Action. Washington, DC (July 1985 ).Google Scholar
  40. Pan American Health Organization (1987). EPI Newslett. 9, 1-5.Google Scholar
  41. Pan American Health Organization (1988). Sixth Meeting of the EPI Technical Advisory Group on Polio Eradication in the Americas. Buenos Aires (November 1988 ).Google Scholar
  42. Patriarca, P., Laender, F., Palmeira, G., Couto Oliveira, M. J., Lima Filho, I., de Souza Dantes, M. C., Tenorio Cordeiro, M., Risi, J. B., and Orenstein, W. A. (1988). Lancet 1, 429–432.PubMedCrossRefGoogle Scholar
  43. Pöyry, T., Stenvik, M., and Hovi, T. (1988). Appt. Environ. Microbiol. 54, 371–374.Google Scholar
  44. Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., and Kew, O. M. (1987). Virology 160, 311–322.PubMedCrossRefGoogle Scholar
  45. Sabin, A. B. (1985). J. Infect. Dis. 151, 420–436.PubMedCrossRefGoogle Scholar
  46. Sabin, A. B. and Boulger, L. R. (1973). J. Bio!. Standard. 1, 115–118.CrossRefGoogle Scholar
  47. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Ehrlich, H. A., and Arnheim, N. (1985). Science 230, 1350–1354.PubMedCrossRefGoogle Scholar
  48. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Ehrlich, H. A. (1988). Science 239, 487–491.PubMedCrossRefGoogle Scholar
  49. Sanger, F., Nickten, S., and Coulson, A. R. (1977). Proc. Nati. Acad. Sci. USA 74, 5463–5467.CrossRefGoogle Scholar
  50. Smith, D. B., and Inglis, S. C. (1987). J. Gen. Virol. 68, 2729–2740.PubMedCrossRefGoogle Scholar
  51. Stanway, G., Hughes, P. J., Mountfort, R. C., Reeve, P., Minor, P. D., Schild, G. C., and Almond, J. W. (1984). Proc. Nati. Acad. Sci. USA 81, 1539–1543.Google Scholar
  52. Steinhauer, D. A., and Holland, J. J. (1987). Annu. Rev. Microbiol. 41, 409–433.PubMedCrossRefGoogle Scholar
  53. Studencki, A. B., and Wallace, R. B. (1984). DNA 3, 269–277.CrossRefGoogle Scholar
  54. Takeda, N., Miyamura, K., Ogino, T., Natori, K., Yamazaki, S., Sakurai, N., Nakazono, N., Ishii, K., and Kono, R. (1984). Virology 134, 375–388.PubMedCrossRefGoogle Scholar
  55. Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., and Nomoto, A. (1984). J. Mol. Bio!. 174, 561–585.CrossRefGoogle Scholar
  56. Toyoda, H., Nicklin, M. J. H., Murray, M. G., Anderson, C. W., Dunn, J. J., Studier, F. W., and Wimmer, E. (1986). Cell 45, 761–770.PubMedCrossRefGoogle Scholar
  57. van Wezel, A. L., and Hazendonk, A. G. (1979). Intervirology 11, 2–8.PubMedCrossRefGoogle Scholar
  58. White, C. M., and Bancroft, E. C. (1982). J. Bio!. Chem. 257, 8569–8572.Google Scholar
  59. World Health Assembly (1988). Global Eradication of Poliomyelitis by the Year 2000. Resolution WHA41.28, Geneva (May 1988 ).Google Scholar
  60. World Health Organization (1988). Weekly Epidemiol. Rec. 63, 249–251.Google Scholar
  61. World Health Organization (1989). Expanded Programme on Immunization, Global Situation—Poliomyelitis, May 1989. Google Scholar
  62. Zimmern, D., and Kaesberg, P. (1978). Proc. Natl. Acad. Sci. USA 75, 4257–4261.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Olen M. Kew
    • 1
  • Baldev K. Nottay
    • 1
  • Rebeca Rico-Hesse
    • 1
  • Mark A. Pallansch
    • 1
  1. 1.Division of Viral Diseases, Center for Infectious DiseasesCenters for Disease ControlAtlantaUSA

Personalised recommendations